Ira Surolia

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Purpose A clinical trial was conducted employing androgen deprivation therapy (ADT) +/-vaccine in patients (pts) with rising prostate specific antigen (PSA) after definitive therapy but no disease visible on bone or computed tomography (CT) scan. The primary endpoint was to determine if a whole tumor cell vaccine could prolong PSA recovery, but a key(More)
  • 1